KELOWNA, BC / ACCESSWIRE / June 6, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it has successfully filed a pre-Investigational New Drug ("IND") meeting request letter with the U.S. Food and Drug Administration ("FDA"). The FDA… Read More..

Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today a publication describing the binding of… Read More..

As BIONIK Laboratories (BNKL) marks National Stroke Awareness Month, Interim CEO, Richard Russo, talks about what's next for the company New York, New York--(Newsfile Corp. - May 25, 2022) - PCG Digital - Stroke is an enormous public health issue that can strike anyone at any time, regardless of age… Read More..